News Contact Us

The ICMR reports Remdesivir to work against COVID-19 replication

Author : Saipriya Iyer | Published Date : 2020-04-14 

The ICMR (Indian Council of Medical Research), the apex biomedical research authority of India, has reportedly stated that an antiviral drug, remdesivir, may turn out to be highly effective to stop the replication of SARS CoV-2, the virus that is responsible for causing coronavirus. Remdesivir was previously used at the time of the Ebola outbreak.

The ICMR stated that research regarding the safety and efficacy to treat COVID-19 is part of a WHO’s Solidarity Trial.

As per a recent study published in the New England Journal of Medicine, two of the three critical coronavirus infected patients relying on ventilators or oxygen support showed improvement when remdesivir was administered to them.

Speaking on the research, Raman R Gangakhedkar, Head of the Epidemiology and Communicable diseases, ICMR stated that remdesivir, which was utilized against Ebola, also restricts reproduction of COVID-19 as per the researchers, which is a prime factor for it to be effective for the treatment of COVID-19.

Gangakhedkar further added that recently reported study on the use of this drug for coronavirus treatment was not a clinical study, but an observational study. From this study, the researchers found that about 68 percent or two of three patients after the administration of remdesivir did not need ventilators or the amount of oxygen support they required decreased. More about the drug efficiency would be known from the WHO Solidarity Trial, which has a division looking into this.

Gilead Sciences Inc. develops the antiviral drug remdesivir, however, it is currently not available in the nation. The Indian government is working to see whether any pharma company can produce this drug locally.

India is seeing a steady growth in the number of COVID-19 patients every day. The number of cases in the country has surged to 9,352 while the death toll has reached 324 as per the stats provided by the Union Health Ministry on Monday. However, according to a PTI tally of the numbers provided by several states on Monday, at least 9,975 people were infected while 346 casualties were reported.   


Source credit: https://www.news18.com/news/india/antiviral-drug-remdesivir-may-be-effective-in-stopping-replication-of-coronavirus-icmr-2576601.html

About Author

Saipriya Iyer

Saipriya Iyer

Saipriya Iyer presently works as a content developer for fractovia.org. Having dabbled with the domain of content creation for nearly half a decade, she now boasts of an enviable portfolio, holding substantial experience in penning down pieces related to technology, finance, and a wide spectrum of other industry verticals. A qualified computer engineering graduate from the University of Pune, Saipriya can often be found leveraging her knowledge of software technology and electronics in her write-ups. She can be contacted at- [email protected] | https://twitter.com/saipriya_i

Related News

GoBear raises $17M funds led by Walvis Participaties & Aegon N.V.

Published Date: 2020-05-28         Author: Saipriya Iyer

GoBear, a Singapore-based fintech firm, has recently raised a new funding round worth $17 million led by Dutch Venture Capital Walvis Participaties & Aegon N.V. The company is a financial supermarket in Asia, which serves the main purpose of improving the financial health of customers. GoBear... Read More

Telstra beats rollout target & launches 5G network across 47 cities

Published Date: 2020-05-27         Author: Saipriya Iyer

Telstra is reportedly building its 5G network ahead of time and has extended its reach across 47 Australian cities. Additionally, the company is unveiling a mobile broadband device that can compete directly with the NBN (National Broadband Network). As per the statement made by Channa Seneviratne... Read More

BigBasket plans to raise $150-200M funds to boost online grocery sales

Published Date: 2020-05-26         Author: Saipriya Iyer

BigBasket is reportedly planning to raise funds worth nearly $150-200 million, owing to the rising opportunities of online grocery sales due to the nationwide COVID-19 lockdown. In the initial days of the lockdown, supply chains were disrupted. However, e-Commerce has emerged subsequently as the ... Read More

© 2020 Fractovia. All Rights Reserved